550 related articles for article (PubMed ID: 10954253)
1. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract][Full Text] [Related]
2. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
[TBL] [Abstract][Full Text] [Related]
3. Hereditary ovarian cancer: molecular genetics and clinical implications.
Boyd J; Rubin SC
Gynecol Oncol; 1997 Feb; 64(2):196-206. PubMed ID: 9038264
[TBL] [Abstract][Full Text] [Related]
4. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
[TBL] [Abstract][Full Text] [Related]
5. [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
[TBL] [Abstract][Full Text] [Related]
6. Risk of breast cancer in carriers of BRCA gene mutations.
Birkmeyer JD; Welch HG
N Engl J Med; 1997 Sep; 337(11):787-8; author reply 789. PubMed ID: 9289638
[No Abstract] [Full Text] [Related]
7. [Molecular genetics of hereditary breast carcinoma].
Hampl M; Chang-Claude J; Schwarz P; Saeger HD; Schackert HK
Zentralbl Chir; 1997; 122(2):67-73. PubMed ID: 9173760
[TBL] [Abstract][Full Text] [Related]
8. Risk of breast cancer in carriers of BRCA gene mutations.
Orlando R
N Engl J Med; 1997 Sep; 337(11):787; author reply 789. PubMed ID: 9289637
[No Abstract] [Full Text] [Related]
9. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.
Gayther SA; Ponder BA
Mol Med Today; 1997 Apr; 3(4):168-74. PubMed ID: 9134530
[TBL] [Abstract][Full Text] [Related]
10. THe genetics of familial breast cancer.
Cannon-Albright LA; Skolnick MH
Semin Oncol; 1996 Feb; 23(1 Suppl 2):1-5. PubMed ID: 8614840
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
12. BRCA genes--bookmaking, fortunetelling, and medical care.
Healy B
N Engl J Med; 1997 May; 336(20):1448-9. PubMed ID: 9145684
[No Abstract] [Full Text] [Related]
13. Genetic susceptibility for breast cancer: testing and primary prevention options.
Baron RH; Borgen PI
Oncol Nurs Forum; 1997 Apr; 24(3):461-8. PubMed ID: 9127359
[TBL] [Abstract][Full Text] [Related]
14. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
17. Risk of breast cancer in carriers of BRCA gene mutations.
Whittemore AS
N Engl J Med; 1997 Sep; 337(11):788-9. PubMed ID: 9289641
[No Abstract] [Full Text] [Related]
18. An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene.
Lancaster JM; Wiseman RW; Berchuck A
Obstet Gynecol; 1996 Feb; 87(2):306-9. PubMed ID: 8559544
[TBL] [Abstract][Full Text] [Related]
19. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
Foulkes WD; Narod SA
Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
[TBL] [Abstract][Full Text] [Related]
20. [Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].
Klijn JG; Devilee P; van Geel AN; Tilanus-Linthorst MM; Dudok-de Wit C; Meijers-Heijboer EJ
Ned Tijdschr Geneeskd; 1995 Mar; 139(9):439-45. PubMed ID: 7891765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
